- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有110家主力机构披露2026-06-30报告期持股数据，持仓量总计8126.29万股，占流通A股18.90%
- 波段诊断：
-
技术面诊股
诊断结果：5.4技术面打败了65%的股票
技术面评分前10的股票
近期的平均成本为15.96元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为15.96元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.96","date":1791965099,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2026.10.15","stock":"-1.98","trade":null,"ind":"-2.43"},{"date":"2026.10.14","stock":"-0.68","trade":null,"ind":"-1.97"},{"date":"2026.10.13","stock":"-1.27","trade":null,"ind":"-0.25"},{"date":"2026.10.12","stock":"-1.49","trade":null,"ind":"-2.03"},{"date":"2026.10.09","stock":"0.36","trade":null,"ind":"0.17"},{"date":"2026.10.08","stock":"-0.48","trade":null,"ind":"-2.07"},{"date":"2026.09.30","stock":"2.70","trade":null,"ind":"-0.11"},{"date":"2026.09.29","stock":"-0.37","trade":null,"ind":"0.34"},{"date":"2026.09.28","stock":"-0.18","trade":null,"ind":"-3.44"},{"date":"2026.09.24","stock":"-1.08","trade":null,"ind":"-2.34"},{"date":"2026.09.23","stock":"0.18","trade":null,"ind":"-0.64"},{"date":"2026.09.22","stock":"0.18","trade":null,"ind":"-0.05"},{"date":"2026.09.21","stock":"4.22","trade":null,"ind":"0.65"},{"date":"2026.09.18","stock":"0.57","trade":null,"ind":"1.72"},{"date":"2026.09.17","stock":"0.90","trade":null,"ind":"-0.33"},{"date":"2026.09.16","stock":"0.51","trade":null,"ind":"1.26"},{"date":"2026.09.15","stock":"-1.77","trade":null,"ind":"-0.72"},{"date":"2026.09.14","stock":"0.64","trade":null,"ind":"-0.64"},{"date":"2026.09.11","stock":"-2.66","trade":null,"ind":"-1.08"},{"date":"2026.09.10","stock":"-1.16","trade":null,"ind":"-0.77"},{"date":"2026.09.09","stock":"-1.98","trade":null,"ind":"0.15"}]
万孚生物,深证成指,医疗器械指数
压力支撑
该股压力位为15.92元，支撑位为15.62元。
[{"text":"\u538b\u529b\u4f4d","value":"15.92","date":1791993600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.62","date":1791993600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了58%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月15日 20:30
| 机构今日流向(万元) | -27.92 | 机构5日流向(万元) | -973.11 |
| 机构10日流向(万元) | -3427.72 | 机构20日流向(万元) | -2690.93 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1120.45万股，其中基金净增仓9家，主力净增仓24家，请投资者中长期谨慎为宜。
截止2026-06-30，共110家主力机构（基金104家，一般法人5家，券商1家），持仓量总计8126.29万股，占流通A股18.90%
其中，基金持仓与2025-12-31相比：
增仓：24家 ，增持 144.23万股
减仓：15家 ，减持 534.35万股
新出现在主力名单中：61家 ，持有854.69万股
从主力名单中消失：37家 ，原持有1288.42万股
其中，基金持仓与2025-12-31相比：
增仓：24家 ，增持 144.23万股
减仓：15家 ，减持 534.35万股
新出现在主力名单中：61家 ，持有854.69万股
从主力名单中消失：37家 ，原持有1288.42万股
消息面诊股
诊断结果：5.8消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 万孚生物：10月13日获融资买入358.57万元
2026-10-14 - 万孚生物：第五届董事会第二十八次会议决议公告
2026-10-13 - 万孚生物：关于召开2026年第五次临时股东会的通知
2026-10-13 - 万孚生物拟终止知识城生产基地募投项目 原承诺投入4
2026-10-13 - 万孚生物：10月9日获融资买入631.42万元
2026-10-12 - 海外麻疹疫情快速抬头，疫苗与体外诊断出海迎来事件催
2026-10-12 - 万孚生物：10月8日获融资买入1383.60万元
2026-10-09 - 万孚生物连续2日融资买入额增长率超50%，多头加速
2026-10-09 - 万孚生物：9月30日获融资买入649.94万元
2026-10-08 - 万孚生物：9月29日获融资买入410.06万元
2026-09-30
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-10-14 |
| 一般消息 | 募资投向 | 预测年新增净利润为:18687.... | 2026-10-13 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-24 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-06-05 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-15 |
| 利好 | 分红转增 | 10派2.2元(含税) | 2026-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-23 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 高管变动 | 因个人工作原因 | 2026-01-23 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-09 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 因公司内部治理结构调整 | 2025-12-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-11 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 2条 | 1条 | 1条 |
行业面诊股
诊断结果：0.0行业面打败了2%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.10.15","price":"-2.43","value":null},{"date":"2026.10.14","price":"-1.97","value":null},{"date":"2026.10.13","price":"-0.25","value":null},{"date":"2026.10.12","price":"-2.03","value":null},{"date":"2026.10.09","price":"0.17","value":null},{"date":"2026.10.08","price":"-2.07","value":null},{"date":"2026.09.30","price":"-0.11","value":null},{"date":"2026.09.29","price":"0.34","value":null},{"date":"2026.09.28","price":"-3.44","value":null},{"date":"2026.09.24","price":"-2.34","value":null},{"date":"2026.09.23","price":"-0.64","value":null},{"date":"2026.09.22","price":"-0.05","value":null},{"date":"2026.09.21","price":"0.65","value":null},{"date":"2026.09.18","price":"1.72","value":null},{"date":"2026.09.17","price":"-0.33","value":null},{"date":"2026.09.16","price":"1.26","value":null},{"date":"2026.09.15","price":"-0.72","value":null},{"date":"2026.09.14","price":"-0.64","value":null},{"date":"2026.09.11","price":"-1.08","value":null},{"date":"2026.09.10","price":"-0.77","value":null},{"date":"2026.09.09","price":"0.15","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 采纳股份 | 47.96% | 2.45% | 5.2分 |
| 2 | 中红医疗 | 43.56% | 13.92% | 6.0分 |
| 3 | 五洲医疗 | 35.70% | -6.70% | 5.6分 |
| 4 | 奥精医疗 | 19.33% | -1.20% | 3.5分 |
| 5 | 洁特生物 | 13.94% | -14.19% | 4.1分 |
| 6 | - | 11.76% | 4.07% | 分 |
| 8 | 蓝帆医疗 | 8.32% | -1.06% | 5.7分 |
| 10 | 楚天科技 | 7.50% | -5.32% | 4.5分 |
| 12 | 东富龙 | 6.81% | -8.53% | 4.8分 |
| 14 | 新产业 | 5.07% | 5.63% | 6.2分 |
| 16 | ST凯利 | 4.19% | 5.38% | 4.8分 |
| 18 | 达安基因 | 3.82% | -4.19% | 5.1分 |
| 20 | 南微医学 | 3.30% | -2.06% | 4.7分 |
| 22 | 戴维医疗 | 2.89% | -7.63% | 4.8分 |
| 24 | 奥泰生物 | 2.21% | -8.45% | 4.6分 |
| 26 | 透景生命 | 2.11% | -6.31% | 4.9分 |
| 28 | 爱博医疗 | 1.58% | 5.58% | 5.7分 |
| 30 | 可孚医疗 | 1.23% | -1.70% | 6.2分 |
| 32 | 迈瑞医疗 | 1.09% | 5.96% | 6.7分 |
| 34 | 圣湘生物 | 0.32% | -2.65% | 4.5分 |
| 36 | 科华生物 | 0.00% | -3.31% | 5.0分 |
| 38 | 仁度生物 | -0.15% | -8.71% | 4.5分 |
| 40 | 科美诊断 | -0.31% | -4.09% | 4.5分 |
| 42 | 三鑫医疗 | -0.67% | -0.99% | 5.6分 |
| 44 | 鱼跃医疗 | -0.70% | -1.62% | 5.3分 |
| 46 | 山东药玻 | -1.03% | 0.55% | 5.6分 |
| 48 | 安旭生物 | -1.22% | -4.67% | 4.4分 |
| 50 | 佰仁医疗 | -1.57% | 1.78% | 4.6分 |
| 52 | 大博医疗 | -1.84% | -0.25% | 6.0分 |
| 54 | 济民健康 | -2.71% | -1.74% | 4.6分 |
| 56 | 万孚生物 | -3.06% | -4.98% | 4.8分 |
| 58 | 威高骨科 | -3.24% | -3.15% | 5.0分 |
| 60 | 心脉医疗 | -3.42% | -0.75% | 5.1分 |
| 62 | 东方生物 | -3.60% | -4.71% | 4.6分 |
| 64 | 安必平 | -3.87% | -10.74% | 4.5分 |
| 66 | 超研股份 | -4.02% | -4.57% | 5.5分 |
| 68 | 冠昊生物 | -4.37% | -6.33% | 4.9分 |
| 70 | 维力医疗 | -4.59% | -2.96% | 5.1分 |
| 72 | - | -4.83% | -3.66% | 分 |
| 74 | 祥生医疗 | -5.28% | -5.83% | 4.6分 |
| 76 | 爱威科技 | -5.52% | -9.46% | 4.8分 |
| 78 | 健尔康 | -5.55% | -3.55% | 5.0分 |
| 80 | 奥美医疗 | -5.65% | -2.07% | 5.2分 |
| 82 | 三友医疗 | -5.81% | -5.16% | 4.7分 |
| 84 | 威高血净 | -6.34% | -2.34% | 4.7分 |
| 86 | 春立医疗 | -6.48% | -7.54% | 4.4分 |
| 88 | *ST明德 | -6.69% | -4.98% | 3.9分 |
| 90 | 翔宇医疗 | -6.98% | -9.77% | 4.2分 |
| 92 | 黄山胶囊 | -7.25% | -6.16% | 5.0分 |
| 94 | 天臣医疗 | -7.71% | -9.57% | 4.5分 |
| 96 | 振德医疗 | -8.11% | -2.60% | 5.3分 |
| 98 | 北芯生命 | -8.24% | -7.47% | 5.3分 |
| 100 | 天智航 | -8.67% | -7.13% | 3.8分 |
| 102 | 山外山 | -8.82% | -3.34% | 4.2分 |
| 104 | 济高发展 | -9.12% | -6.39% | 4.0分 |
| 106 | 东星医疗 | -9.27% | -8.08% | 4.3分 |
| 108 | 伟思医疗 | -9.37% | -7.71% | 4.5分 |
| 110 | 万泰生物 | -9.84% | -4.53% | 4.9分 |
| 112 | - | -10.34% | -5.30% | 分 |
| 114 | 睿昂基因 | -10.55% | -12.64% | 3.8分 |
| 116 | - | -11.13% | -4.27% | 分 |
| 118 | - | -11.75% | -3.96% | 分 |
| 120 | 迈普医学 | -12.13% | -8.61% | 4.1分 |
| 122 | *ST益通 | -12.80% | -3.19% | 3.2分 |
| 124 | - | -13.84% | -10.33% | 分 |
| 126 | 华兰股份 | -14.54% | -15.09% | 3.8分 |
| 128 | 康众科技 | -14.93% | -3.46% | 4.3分 |
| 130 | 赛诺医疗 | -15.62% | -12.18% | 4.7分 |
| 132 | 澳华内镜 | -16.77% | -6.77% | 3.4分 |
| 134 | 浩欧博 | -17.34% | -18.48% | 3.6分 |
| 136 | 英科医疗 | -18.74% | -6.42% | 4.4分 |
| 138 | 力诺药包 | -20.88% | -15.17% | 4.1分 |
| 140 | 乐心股份 | -21.44% | -7.26% | 3.7分 |
| 142 | - | - | -4.77% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 66/244 ， 44/244。
[{"date":"2026-06-30","value":"2.26","vol":"2.35"},{"date":"2026-03-31","value":"1.54","vol":"1.12"},{"date":"2025-12-31","value":"-1.15","vol":"2.37"},{"date":"2025-09-30","value":"2.42","vol":"3.06"},{"date":"2025-06-30","value":"3.41","vol":"2.40"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.26 | 1.54 | -1.15 | 2.42 | 3.41 |
| 行业(%) | 2.35 | 1.12 | 2.37 | 3.06 | 2.40 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"63.53","vol":"52.38"},{"date":"2026-03-31","value":"63.24","vol":"52.12"},{"date":"2025-12-31","value":"56.98","vol":"51.82"},{"date":"2025-09-30","value":"60.30","vol":"52.03"},{"date":"2025-06-30","value":"62.87","vol":"52.36"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
63.53 | 63.24 | 56.98 | 60.30 | 62.87 |
| 行业(%) | 52.38 | 52.12 | 51.82 | 52.03 | 52.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 119/244 ， 94/244。
[{"date":"2026-06-30","value":"-16.63","vol":"5.46"},{"date":"2026-03-31","value":"-27.31","vol":"5.59"},{"date":"2025-12-31","value":"-31.91","vol":"1.01"},{"date":"2025-09-30","value":"-22.52","vol":"0.11"},{"date":"2025-06-30","value":"-20.92","vol":"-1.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-16.63 | -27.31 | -31.91 | -22.52 | -20.92 |
| 行业(%) | 5.46 | 5.59 | 1.01 | 0.11 | -1.37 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-35.24","vol":"-24.55"},{"date":"2026-03-31","value":"-55.38","vol":"-20.93"},{"date":"2025-12-31","value":"-111.22","vol":"-33.44"},{"date":"2025-09-30","value":"-69.32","vol":"-15.21"},{"date":"2025-06-30","value":"-46.82","vol":"-17.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-35.24 | -55.38 | -111.22 | -69.32 | -46.82 |
| 行业(%) | -24.55 | -20.93 | -33.44 | -15.21 | -17.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/244 ， 44/244。
[{"date":"2026-06-30","value":"0.16","vol":"0.17"},{"date":"2026-03-31","value":"0.09","vol":"0.08"},{"date":"2025-12-31","value":"0.30","vol":"0.35"},{"date":"2025-09-30","value":"0.24","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.09 | 0.30 | 0.24 | 0.18 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.25 | 0.17 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.25","vol":"1.12"},{"date":"2026-03-31","value":"0.77","vol":"0.55"},{"date":"2025-12-31","value":"2.81","vol":"2.33"},{"date":"2025-09-30","value":"1.90","vol":"1.66"},{"date":"2025-06-30","value":"1.31","vol":"1.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.25 | 0.77 | 2.81 | 1.90 | 1.31 |
| 行业(次) | 1.12 | 0.55 | 2.33 | 1.66 | 1.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 9/244 ， 40/244。
[{"date":"2026-06-30","value":"45.06","vol":"14.81"},{"date":"2026-03-31","value":"37.50","vol":"-0.33"},{"date":"2025-12-31","value":"103.45","vol":"32.14"},{"date":"2025-09-30","value":"24.53","vol":"14.86"},{"date":"2025-06-30","value":"20.76","vol":"15.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 45.06 | 37.50 | 103.45 | 24.53 | 20.76 |
| 行业 | 14.81 | -0.33 | 32.14 | 14.86 | 15.69 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.60","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.13","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.91","vol":"1.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.60 | - | 1.13 | - | 0.91 |
| 行业 | 1.31 | 0.00 | 1.62 | 0.01 | 1.58 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 55/244 ， 57/244。
[{"date":"2026-06-30","value":"3.32","vol":"5.78"},{"date":"2026-03-31","value":"3.22","vol":"6.17"},{"date":"2025-12-31","value":"3.18","vol":"5.27"},{"date":"2025-09-30","value":"7.78","vol":"5.64"},{"date":"2025-06-30","value":"5.72","vol":"5.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.32 | 3.22 | 3.18 | 7.78 | 5.72 |
| 行业 | 5.78 | 6.17 | 5.27 | 5.64 | 5.45 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.50","vol":"4.71"},{"date":"2026-03-31","value":"2.61","vol":"5.04"},{"date":"2025-12-31","value":"2.47","vol":"4.13"},{"date":"2025-09-30","value":"6.59","vol":"4.49"},{"date":"2025-06-30","value":"4.91","vol":"4.34"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.50 | 2.61 | 2.47 | 6.59 | 4.91 |
| 行业 | 4.71 | 5.04 | 4.13 | 4.49 | 4.34 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 72/244 ， 71/244。
[{"date":"2026-06-30","value":"18.28","vol":"23.17"},{"date":"2026-03-31","value":"17.17","vol":"22.26"},{"date":"2025-12-31","value":"17.09","vol":"23.19"},{"date":"2025-09-30","value":"16.42","vol":"22.23"},{"date":"2025-06-30","value":"18.44","vol":"22.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.28 | 17.17 | 17.09 | 16.42 | 18.44 |
| 行业(%) | 23.17 | 22.26 | 23.19 | 22.23 | 22.18 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.23","vol":"0.42"},{"date":"2026-03-31","value":"0.21","vol":"0.40"},{"date":"2025-12-31","value":"0.21","vol":"0.41"},{"date":"2025-09-30","value":"0.20","vol":"0.72"},{"date":"2025-06-30","value":"0.23","vol":"0.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.23 | 0.21 | 0.21 | 0.20 | 0.23 |
| 行业(%) | 0.42 | 0.40 | 0.41 | 0.72 | 0.58 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2026-10-01 | 买入 | |
| 华创证券 | 2026-09-30 | 增持 | |
| 华泰证券 | 2026-08-27 | 买入 | 买入 |
| 兴业证券 | 2026-07-26 | 增持 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"11.97","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.88","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.62","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.63","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"3.69","blueLineValue":"0.79","type":"YC"}]